Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation.The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.
《骨髓移植》发表高质量的、同行评审的原创研究，涉及造血干细胞移植的基础生物学和临床应用的各个方面。因此，该杂志的广泛范围涵盖了干细胞生物学等主题，例如：动力学和细胞因子控制，移植免疫学，HLA和匹配技术、转化研究和特定移植方案的临床结果。《骨髓移植》每年出版24期。
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0465-9
Cord blood research, banking, and transplantation: achievements, challenges, and perspectives
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0546-9
Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0721-z
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0543-z
Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0583-4
EASIX and mortality after allogeneic stem cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0703-1
Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0577-2
Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005–2015
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0554-9
Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0544-y
Pediatric acute GVHD: clinical phenotype and response to upfront steroids
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0651-9
Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0681-3
T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0462-z
Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0501-9
Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donors
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0575-4
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0674-2
PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0766-z
FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0456-x
Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0752-5
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0722-y
Acute respiratory failure and the kinetics of neutrophil recovery in pediatric hematopoietic cell transplantation: a multicenter study
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0649-3
High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0440-5
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0673-3
Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0738-3
Direct adjusted survival and cumulative incidence curves for observational studies
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0552-y
Cataracts and wine
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0433-4
Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0755-2
Pretransplant FLT3-ITD levels predict outcome after allogeneic hematopoietic cell transplantation for AML patients in the first remission
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0576-3
Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0632-z
A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0757-0
Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0585-2
Retrospective cohort study comparing the outcomes of intravenous busulfan vs. total-body irradiation after single cord blood transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0441-4
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0745-4
Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0765-0
Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0436-1
My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0711-1
Haemopoietic cell transplants, corneal transplants and champagne
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0551-z
Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0663-5
A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0534-0
Correction: Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0706-y
Successful treatment of refractory CMV colitis after haploidentical HSCT with post-transplant cyclophosphamide using CD45RA+ depleted donor lymphocyte infusion
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0685-z
What is the role of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia?
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0584-3
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0509-1
Low incidence of hemorrhagic cystitis following ex vivo T-cell depleted haploidentical hematopoietic cell transplantation in children
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0672-4
Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graft
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0723-x
A noninvasive diagnostic approach using per-rectal portal scintigraphy for sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0537-x
Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0675-1
Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0655-5
Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-up
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0671-5
Investigation of TGFB1 −1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0656-4
Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation
来源期刊：Bone Marrow TransplantationDOI：10.1038/s41409-019-0586-1
